Patents by Inventor Kathleen McGuire

Kathleen McGuire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MACROCYCLIC PEPTIDES AND METHODS FOR MAKING AND USING THEM
    Publication number: 20090264345
    Abstract: The invention provides novel macrocyclic peptides and methods for their preparation. The invention also provides pharmaceutical compositions and methods to treat, prevent or ameliorate a cell proliferative disease or conditions. e.g., a cancer. in a subject in need thereof, including but not limited to a colon cancer, such as MSS or MSI colon cancer, and pancreatic cancer. This invention provides for the synthesis and development of novel anticancer agents that are based on the core structure Sansalvamide A (San A).
    Type: Application
    Filed: March 19, 2007
    Publication date: October 22, 2009
    Applicant: San Diego State University Research Foundation
    Inventors: Shelli R. McAlpine, Kathleen McGuire
  • H. saimiri-HTLV-X region vector
    Patent number: 5424197
    Abstract: An H. saimiri-HTLV-1 or 2 X region vector is disclosed. This vector can be used to establish continuous cell lines of difficult to grow cells, such as human T-cells. It can also be used to obtain certain cell products and in methods for screening new compounds.
    Type: Grant
    Filed: November 16, 1992
    Date of Patent: June 13, 1995
    Assignees: Dana Farber Cancer Institute, Behringwerke Aktiengesellschaft
    Inventors: William A. Haseltine, Kathleen McGuire, Marie-Christine Dokhelar, Ralph Grassmann, Bernard Fleckenstein, Ingrid Muller-Fleckenstein